Sector portfolio · Corporate investor · United States

Amgen's Biotech portfolio

Amgen has backed 19 Biotech startups in rounds we track, $2.6B between them, shown by the stage each has reached. The best-funded is Kymera Therapeutics.

19startups backed
4stages
$2.6Braised between them
Series C and laterbiggest stage

Amgen's profile

Series C and later

8

Stage not reported

5

Series B

4

Series A

2

Segment by segment

Series C and later

8 startups · $1.6B raised

  1. Kymera TherapeuticsKymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.United States$799M
  2. Science 37Science 37 is a clinical research company that facilitates universal participation in clinical trials for patients and providers.United States$236M
  3. Obsidian TherapeuticsObsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.United States$210M
  4. STSiteOne TherapeuticsUnited States$119M
  5. CPCalistoga PharmaceuticalsCalistoga Pharmaceuticals develops therapeutic oral medicines for patients suffering from cancer and inflammatory diseases.United States$97M
  6. AkiliAkili is long Africa, permanent capital.United States$68M
  7. ImmaticsImmatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors withGermany$58M
  8. SyapseSyapse is a real-world evidence company dedicated to extinguishing the fear and burden of serious disease by advancing real-world United States$45M

Stage not reported

5 startups · $585M raised

  1. EpizymeEpizyme is a biopharmaceutical company focusing on treatments for blood cancer and tumors.United States$332M
  2. PPrecisionUnited States$111M
  3. AetionAetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.United States$74M
  4. InteKrinInteKrin Therapeutics is focused on developing and commercializing therapeutics for neuroendocrine, metabolic and immune disorders.United States$65M
  5. OCOncofactor CorporationOncofactor develops cancer therapeutics that disrupt signaling pathways between tumors and the immune system.United States$3.1M

Series B

4 startups · $366M raised

  1. Senti BiosciencesSenti Biosciences is a biotechnology company that focuses on synthetic biology and gene circuit engineering for therapeutic applications.United States$169M
  2. QurAlisQurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.United States$94M
  3. IBImago BioSciencesImago is a clinical stage biopharmaceutical company that develops drugs for the management of proliferative diseases of the bone marrow.United States$67M
  4. AAllozyneAllozyne develops technologies that improve the efficacy, safety, dosing, and other characteristics of protein-based therapeutics.United States$37M

Series A

2 startups · $26M raised

  1. VTViron TherapeuticsViron Therapeutics is a Biotechnology companyCanada$20M
  2. ATAcylin TherapeuticsAcylin Therapeutics operates in the pharmaceutical and drug manufacturing industry developing inhibitors of cellular acetylation.United States$6.4M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Amgen as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Co-investorsWho invests with Amgen21 co-investorsSector portfolioCoinbase Ventures' Web3 & Crypto portfolio168 startups · $5.7BSector portfolioSalesforce Ventures' AI portfolio115 startups · $181BSector portfolioGoogle Ventures' AI portfolio81 startups · $16BSector portfolioGoogle Ventures' Biotech portfolio74 startups · $12BSector portfolioSamsung Next's AI portfolio72 startups · $9.8B

Raising from investors like Amgen?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps